Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ellagic acid ameliorates neuroinflammation and demyelination in experimental autoimmune encephalomyelitis: Involvement of NLRP3 and pyroptosis
Zahra Kiasalari, Siamak Afshin‐Majd, Tourandokht Baluchnejadmojarad, et al.
Journal of Chemical Neuroanatomy (2020) Vol. 111, pp. 101891-101891
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Dietary Phenolic Compounds: Their Health Benefits and Association with the Gut Microbiota
Yoko Matsumura, Masahiro Kitabatake, Shin-ichi Kayano, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 880-880
Open Access | Times Cited: 59
Remodeling of the Intra‐Conduit Inflammatory Microenvironment to Improve Peripheral Nerve Regeneration with a Neuromechanical Matching Protein‐Based Conduit
Jia‐Yi Wang, Ya Yuan, John H. Zhang, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 15
The bioactivity and applications of pomegranate peel extract: A review
Qiwen Xiang, Meifeng Li, Jiayu Wen, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 7
Closed Access | Times Cited: 66
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis
Behnam Hashemi, Maryam Abdollahi, Sanaz Abbaspour‐Aghdam, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114195-114195
Open Access | Times Cited: 21
Effectiveness of targeting the NLRP3 inflammasome by using natural polyphenols: A systematic review of implications on health effects
Taotao Wang, Hong Xu, Ruixia Dong, et al.
Food Research International (2023) Vol. 165, pp. 112567-112567
Closed Access | Times Cited: 20
Mechanistic insight into immunomodulatory effects of food-functioned plant secondary metabolites
A.S.M. Ali Reza, Shamima Nasrin, Md. Amjad Hossen, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 22, pp. 5546-5576
Closed Access | Times Cited: 40
Mechanisms Underlying Neurodegenerative Disorders and Potential Neuroprotective Activity of Agrifood By-Products
Cristina Angeloni, Marco Malaguti, Cecilia Prata, et al.
Antioxidants (2022) Vol. 12, Iss. 1, pp. 94-94
Open Access | Times Cited: 23
Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson's disease
Ran Zhao, Nan Jia, Shuyang Wu, et al.
International Journal of Biological Macromolecules (2025), pp. 141814-141814
Closed Access
Depression in Multiple Sclerosis: Lifestyle Interventions as an Additional Therapeutical Approach: A Narrative Review
Matea Hudolin, Hrvoje Budinčević, Dunja Degmečić, et al.
Psychiatry International (2025) Vol. 6, Iss. 1, pp. 34-34
Open Access
Artesunate alleviated hippocampal neuron pyroptosis by down-regulating NLRP3 in rats with cerebral small vessel disease
X Wang, Hequan Zhong, Xiangyu Kong, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Open Access
Phenols and terpenoids: natural products as inhibitors of NLRP3 inflammasome in cardiovascular diseases
Fang Hua, Lingli Shi, Peng Zhou
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 137-147
Closed Access | Times Cited: 19
Trimethylamine N-oxide promotes demyelination in spontaneous hypertension rats through enhancing pyroptosis of oligodendrocytes
Xiaotan Ji, Long Tian, Shenna Niu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 19
How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation
Jessica Rebeaud, Benjamin Peter, Caroline Pot
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10128-10128
Open Access | Times Cited: 17
Natural compounds as potential therapeutic candidates for multiple sclerosis: Emerging preclinical evidence
Jinfeng Yuan, Yanlin Tao, Mengxue Wang, et al.
Phytomedicine (2023) Vol. 123, pp. 155248-155248
Closed Access | Times Cited: 9
Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy
Yu-Xin Guo, Yuan Zhang, Yuhan Gao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Maillard Browning Inhibition by Ellagic Acid via Its Adduct Formation with the Amadori Rearrangement Product
Heping Cui, Ziyan Wang, Mengyu Ma, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 34, pp. 9924-9933
Closed Access | Times Cited: 13
Healthy Properties of a New Formulation of Pomegranate-Peel Extract in Mice Suffering from Experimental Autoimmune Encephalomyelitis
G Vallarino, Annalisa Salis, Elena Lucarini, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 914-914
Open Access | Times Cited: 9
Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
Xuxu Xu, Chaowei Han, Pengcheng Wang, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Ellagic acid effects on disease severity, levels of cytokines and T-bet, RORγt, and GATA3 genes expression in multiple sclerosis patients: a multicentral-triple blind randomized clinical trial
Sahar Jafari Karegar, Naheed Aryaeian, Ghazaleh Hajiluian, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 5
Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management
Seth Woodfin, S. S. HALL, Alexis Ramerth, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2996-2996
Open Access | Times Cited: 1
Exploring the highly selective Fe(III) and Al(III) triggered “OFF-ON” ellagic acid based fluorescent sensor: Spectroscopic, structural elucidations and dual-response mechanism
Yuanyue Wang, Yu Li, Xiaoqing Feng, et al.
Journal of Molecular Liquids (2023) Vol. 381, pp. 121809-121809
Closed Access | Times Cited: 3
Anti-Inflammatory Mechanism of Walnut Meal Peptide/ Ellagic Acid Nanoparticles on LPS-Stimulated RAW264.7 Cells by Inhibition of NF-κB and MAPK Activation
Yuxi Ling, Yanxia Feng, Ziqi Li, et al.
International Journal of Peptide Research and Therapeutics (2023) Vol. 29, Iss. 6
Closed Access | Times Cited: 3
Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis
Renee A. Rotolo, Jennifer Demuro, Gregory Drummond, et al.
Journal of Neuroimmunology (2021) Vol. 356, pp. 577603-577603
Closed Access | Times Cited: 7
Intraperitoneal injection but not oral administration of ellagic acid: A novel immunomodulator via targeting casein kinase 2 signaling pathway
Wenhui Qi, Bing Han, Tingting Cui, et al.
Deleted Journal (2024)
Open Access
Page 1 - Next Page

Scroll to top